Currently, there are upwards of six million people in the United States alone living with Alzheimer’s disease. As some researchers work to determine the exact cause of this neurodegenerative…
Pursuing an Alzheimer’s disease diagnosis can not only be costly, but time-consuming. It may take numerous neuropsychological examinations, alongside other testing and analysis, to confirm this diagnosis. The issue is…
The number of Alzheimer’s disease diagnoses has been rising rapidly over the last few decades. Today, an estimated 6.5 million Americans alone are living with this disease. Yet there…
The study was intended to recruit 6,000 Alzheimer's patients, but even after recruiting had proceeded for seven months, just 29 patients were enrolled. As a result, the trial was cancelled,…
The Irish Times recently featured a book by Dr. Karl Herrup about “How Not to Study a Disease." Dr. Herrup is clear that he opposes the theory that the amyloid…
Alzheimer’s disease is the primary cause of the progressive decline of cognitive function in the elderly. It is characterized by underlying complications in the central nervous system (CNS). To date,…
According to information from the National Institute of Health, one in nine elderly people in the U.S. will be affected by Alzheimer’s disease (AD). A recent article in the Globe Newswire…
Professor Miranda Orr of Winston Salem’s School of Medicine in North Carolina leads a team of investigators who have detected senescent cells in patients with Alzheimer’s disease. These cells, found…
Most people have heard of Viagra, and they know it as a treatment for erectile dysfunction (ED). Fewer people know it as Revatio, which is indicated for pulmonary arterial hypertension…
Eureka Alert recently published a statement by a team of researchers that early results of a new method of treating Alzheimer’s have been “absolutely spectacular.” The new antibody-based therapy…
According to a recent article published in Science Daily, twenty years of research is being challenged by a team of Cambridge University scientists. The new findings of the team of…
When you are looking for new treatments that will either stop or slow the development of Alzheimer’s disease, where would you look? According to a recent article in Gladstone…
The Times Now News recently featured an article that highlighted a study by a group of NYU Langone scientists. The study paper was published October 6th, 2021 in the…
According to a recent article in Biospace, Eisai Pharmaceutical and Biogen Biotechnology recently announced updates to their Phase IIB study 201 and a five-year open-label extension (OLE) studies using lecanemab…
Author Lauren Wellbank recently interviewed Dr. Sara Candler, Director of the Iora Care Team, for a special edition of Martha Stewart’s Health and Wellness. The interview focused on dementia and…
Fenchol, a natural compound, is known for its herbal and appealing scent. This compound is found in a number of plants, including basil, nutmeg, and eucalyptus leaves. In the past,…
Over the years, an inordinate amount of time and resources have been spent on the search for the cause of Alzheimer’s disease. According to a recent article in Medical News…
The Arizona Bioindustry Association recently published an article stating that researchers at Arizona University are now proceeding to a Phase 2b clinical trial for a newly developed therapy for Alzheimer's. The…
According to a recent article in Science Daily, the WHO lists Alzheimer’s disease as the cause of dementia in approximately seventy percent of cases worldwide or a total of twenty-four…
Have you ever heard of a “chaperone” protein? Well, the term pretty much refers to proteins which help direct the way that proteins fold, or a protein which leads “quality…
The article appeared on August 17th in the print issue of the National Academy of Sciences. The study offers an in-depth understanding of the underappreciated function of brain cholesterol. A…
Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…
In the past, researchers have noted an association between neuroinflammation (inflammation of nervous system tissue) and Alzheimer’s disease. However, researchers often believed that neuroinflammation was more of a result of…
In mid-August 2021, Parkinson's News Today reported that dosing was complete in a Phase 2a clinical trial. During the trial, researchers were evaluated ANVS401, an investigational compound for patients…
Breakthrough Therapy designation is granted by the FDA as a way to accelerate drug development and review. In particular, the designation is granted to drugs or biologics for serious conditions,…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
